E-ISSN 2231-170X | ISSN 2231-1696
 

Original Article 


ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj.

Abstract
Diabetic nephropathy (DN) is a major microvascular complication accounting for about 30% of End-Stage Renal Disease (ESRD) cases. An insertion/deletion (I/D) polymorphism of the gene encoding angiotensin-I converting enzyme (ACE) is reported to be a candidate gene predisposing to diabetic nephropathy. Accordingly, we investigated the ACE I/D gene polymorphism in 52 Type 2 diabetes mellitus (T2DM) cases suffering from nephropathy as assessed by 24 hrs urinary protein levels. 50 age and sex matched healthy subjects served as controls. ACE I/D genotyping was carried out by polymerase chain reaction (PCR) amplification using allele specific primers. The frequencies of ACE DD, ID and II genotypes in the diabetic nephropathy patients were 38.5% , 50% and 11.5% and in the control subjects, 22%, 38% and 40% respectively. There was an increase of 16.5% in the frequency of DD genotype in the patients compared to controls. The frequency of D allele in the patients was 63% which was found to be statistically significant (p< 0.05, Odds ratio=2.6) compared to 41% in the controls. These results indicate that Type 2 diabetic patients with D allele (those with DD & ID genotypes) have more than two fold risk of developing nephropathy. Clinical implications of ACE genotyping in planning for patient’s management have been discussed.

Key words: ACE gene polymorphism, Diabetic nephropathy, Genetic risk, Clinical implications


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by M. Kaleemullah Khan
Articles by N. Parimala
Articles by Mohammed Ishaq
Articles by Mohammed Siraj
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. J Med Allied Sci. 2011; 1(1): 42-45.


Web Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. https://jmas.in/?mno=210083 [Access: December 04, 2023].


AMA (American Medical Association) Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. J Med Allied Sci. 2011; 1(1): 42-45.



Vancouver/ICMJE Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. J Med Allied Sci. (2011), [cited December 04, 2023]; 1(1): 42-45.



Harvard Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj (2011) ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. J Med Allied Sci, 1 (1), 42-45.



Turabian Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. 2011. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. Journal of Medical and Allied Sciences, 1 (1), 42-45.



Chicago Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. "ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications." Journal of Medical and Allied Sciences 1 (2011), 42-45.



MLA (The Modern Language Association) Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj. "ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications." Journal of Medical and Allied Sciences 1.1 (2011), 42-45. Print.



APA (American Psychological Association) Style

M. Kaleemullah Khan, N. Parimala, Mohammed Ishaq, Mohammed Siraj (2011) ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. Journal of Medical and Allied Sciences, 1 (1), 42-45.